IR@PKUHSC  > 北京大学药学院  > 化学生物学系
学科主题药学
Forever innovative - A sidelight of researches of inorganic biochemistry in China for celebrating the 80(th) birthday of Professor Wang Kui
Xu Huibi1; Yang Xiaoda2
关键词Wang Kui bioinorganic chemistry rare earths
刊名PROGRESS IN CHEMISTRY
2008-05-01
20期:5页:625-628
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Chemistry, Multidisciplinary
研究领域[WOS]Chemistry
英文摘要

In 1984, the 1(st) Chinese Chemical Society National Conference on Inorganic Biochemistry was held in Wuhan, announcing the start of researches of inorganic biochemistry in China. As one of the founders for inorganic biochemical researches in China, professor Wang Kui initiated and made great contributions to the development of inorganic cytochemistry. This paper presents a brief review on the studies of interaction of inorganic compounds with cells with focusing on the works done by Prof. Wang′s group.

语种中文
WOS记录号WOS:000256204100001
引用统计
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/61158
专题北京大学药学院_化学生物学系
作者单位1.Huazhong Univ Sci & Technol, Dept Chem, Wuhan 430074, Peoples R China
2.Peking Univ, Hlth Sci Ctr, Sch Pharmaceut Sci, Dept Biol Chem, Beijing 100083, Peoples R China
推荐引用方式
GB/T 7714
Xu Huibi,Yang Xiaoda. Forever innovative - A sidelight of researches of inorganic biochemistry in China for celebrating the 80(th) birthday of Professor Wang Kui[J]. PROGRESS IN CHEMISTRY,2008,20(5):625-628.
APA Xu Huibi,&Yang Xiaoda.(2008).Forever innovative - A sidelight of researches of inorganic biochemistry in China for celebrating the 80(th) birthday of Professor Wang Kui.PROGRESS IN CHEMISTRY,20(5),625-628.
MLA Xu Huibi,et al."Forever innovative - A sidelight of researches of inorganic biochemistry in China for celebrating the 80(th) birthday of Professor Wang Kui".PROGRESS IN CHEMISTRY 20.5(2008):625-628.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Xu Huibi]的文章
[Yang Xiaoda]的文章
百度学术
百度学术中相似的文章
[Xu Huibi]的文章
[Yang Xiaoda]的文章
必应学术
必应学术中相似的文章
[Xu Huibi]的文章
[Yang Xiaoda]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。